Lead Product(s): Treprostinil
Therapeutic Area: Pulmonary/Respiratory Diseases
Highest Development Status: Phase III Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 24, 2020
First pivotal clinical trial to demonstrate a benefit in PH-ILD. NDA supplement to be filed by mid-year.